Public Sector Pension Investment Board Increases Stock Position in Kenvue Inc. $KVUE

Key Points

• The Public Sector Pension Investment Board increased its stake in Kenvue Inc. by 8.6% during the first quarter, owning 260,416 shares worth approximately $6.25 million now.
• Kenvue has announced a quarterly dividend increase to $0.2075 per share, yielding 3.9%, with the payout scheduled for August 27th.
• Analysts have mixed sentiments on Kenvue, as several firms reduced their target price, leading to a current consensus rating of "Hold" with a price target of $24.38.

Public Sector Pension Investment Board lifted its position in shares of Kenvue Inc. (NYSE:KVUE - Free Report) by 8.6% during the first quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 260,416 shares of the company's stock after buying an additional 20,517 shares during the quarter. Public Sector Pension Investment Board's holdings in Kenvue were worth $6,245,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of the company. Fulton Bank N.A. lifted its stake in Kenvue by 0.6% in the 1st quarter. Fulton Bank N.A. now owns 78,888 shares of the company's stock worth $1,892,000 after purchasing an additional 465 shares in the last quarter. Scott & Selber Inc. lifted its stake in Kenvue by 0.4% in the 1st quarter. Scott & Selber Inc. now owns 106,621 shares of the company's stock worth $2,557,000 after purchasing an additional 475 shares in the last quarter. Wealth Alliance LLC lifted its stake in Kenvue by 1.6% in the 1st quarter. Wealth Alliance LLC now owns 31,778 shares of the company's stock worth $762,000 after purchasing an additional 486 shares in the last quarter. Everett Harris & Co. CA lifted its stake in Kenvue by 1.4% in the 1st quarter. Everett Harris & Co. CA now owns 36,971 shares of the company's stock worth $887,000 after purchasing an additional 500 shares in the last quarter. Finally, Transatlantique Private Wealth LLC lifted its stake in Kenvue by 5.7% in the 4th quarter. Transatlantique Private Wealth LLC now owns 10,680 shares of the company's stock worth $228,000 after purchasing an additional 580 shares in the last quarter. Hedge funds and other institutional investors own 97.64% of the company's stock.

Analysts Set New Price Targets

Several brokerages have recently issued reports on KVUE. Royal Bank Of Canada decreased their target price on shares of Kenvue from $24.00 to $22.00 and set a "sector perform" rating on the stock in a research report on Friday, August 8th. Citigroup decreased their target price on shares of Kenvue from $24.50 to $22.00 and set a "neutral" rating on the stock in a research report on Tuesday, July 15th. Bank of America decreased their target price on shares of Kenvue from $27.00 to $25.00 and set a "buy" rating on the stock in a research report on Tuesday, July 15th. Barclays decreased their target price on shares of Kenvue from $23.00 to $22.00 and set an "equal weight" rating on the stock in a research report on Tuesday, July 15th. Finally, Canaccord Genuity Group decreased their target price on shares of Kenvue from $29.00 to $26.00 and set a "buy" rating on the stock in a research report on Friday, August 8th. Five investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat.com, the company has an average rating of "Hold" and an average target price of $24.38.

Kenvue Trading Up 1.8%

KVUE stock traded up $0.3850 during mid-day trading on Tuesday, reaching $21.4850. The company had a trading volume of 13,900,327 shares, compared to its average volume of 17,538,854. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.98 and a quick ratio of 0.68. The company has a market capitalization of $41.23 billion, a PE ratio of 29.03, a price-to-earnings-growth ratio of 3.05 and a beta of 0.83. The firm has a 50 day moving average of $21.54 and a 200 day moving average of $22.43. Kenvue Inc. has a 12 month low of $19.75 and a 12 month high of $25.17.

Kenvue (NYSE:KVUE - Get Free Report) last issued its earnings results on Thursday, August 7th. The company reported $0.29 EPS for the quarter, topping analysts' consensus estimates of $0.28 by $0.01. The business had revenue of $3.84 billion for the quarter, compared to the consensus estimate of $3.94 billion. Kenvue had a net margin of 9.37% and a return on equity of 20.06%. The company's revenue for the quarter was down 4.0% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.32 EPS. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. On average, equities analysts predict that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, August 27th. Stockholders of record on Wednesday, August 13th will be given a $0.2075 dividend. This represents a $0.83 annualized dividend and a dividend yield of 3.9%. The ex-dividend date of this dividend is Wednesday, August 13th. This is a boost from Kenvue's previous quarterly dividend of $0.21. Kenvue's dividend payout ratio is currently 112.16%.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.